Dr. Gerarda Cappuccio, a physician-scientist at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, has been selected to receive the 2022 postdoctoral fellowship award from Autism Speaks to test gene therapy for a rare disorder, MeCP2 Duplication Syndrome, a condition related to the over-expression of a gene MeCP2 linked to autism.
